DE69735883D1 - Methode zur behandlung von muskelkrankheiten - Google Patents

Methode zur behandlung von muskelkrankheiten

Info

Publication number
DE69735883D1
DE69735883D1 DE69735883T DE69735883T DE69735883D1 DE 69735883 D1 DE69735883 D1 DE 69735883D1 DE 69735883 T DE69735883 T DE 69735883T DE 69735883 T DE69735883 T DE 69735883T DE 69735883 D1 DE69735883 D1 DE 69735883D1
Authority
DE
Germany
Prior art keywords
treatment
muscle diseases
muscle
diseases
igf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69735883T
Other languages
English (en)
Other versions
DE69735883T2 (de
Inventor
Geoffrey Goldspink
Shi Yu Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Application granted granted Critical
Publication of DE69735883D1 publication Critical patent/DE69735883D1/de
Publication of DE69735883T2 publication Critical patent/DE69735883T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69735883T 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten Expired - Lifetime DE69735883T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9605124 1996-03-11
GBGB9605124.8A GB9605124D0 (en) 1996-03-11 1996-03-11 Method of treating muscular disorders
PCT/GB1997/000658 WO1997033997A1 (en) 1996-03-11 1997-03-11 Method of treating muscular disorders

Publications (2)

Publication Number Publication Date
DE69735883D1 true DE69735883D1 (de) 2006-06-22
DE69735883T2 DE69735883T2 (de) 2007-04-19

Family

ID=10790201

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69735883T Expired - Lifetime DE69735883T2 (de) 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten
DE69739737T Expired - Lifetime DE69739737D1 (de) 1996-03-11 1997-03-11 Methode zur Behandlung von Muskelkrankheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69739737T Expired - Lifetime DE69739737D1 (de) 1996-03-11 1997-03-11 Methode zur Behandlung von Muskelkrankheiten

Country Status (10)

Country Link
US (1) US6221842B1 (de)
EP (2) EP0894136B1 (de)
JP (1) JP2000506729A (de)
AT (2) ATE454451T1 (de)
DE (2) DE69735883T2 (de)
DK (2) DK1726651T3 (de)
ES (2) ES2265649T3 (de)
GB (1) GB9605124D0 (de)
PT (2) PT1726651E (de)
WO (1) WO1997033997A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031517A1 (en) * 1994-05-16 1995-11-23 Shell Internationale Research Maatschappij B.V. Process for upgrading residual hydrocarbon oils
US7118752B2 (en) * 1998-07-22 2006-10-10 University Of Connecticut Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I
US7700353B2 (en) * 1998-07-22 2010-04-20 E-P Therapeutics, Inc. Compositions and methods for inducing apoptosis in tumor cells
GB9926968D0 (en) * 1999-11-15 2000-01-12 Univ London Treatment of neurological disorders
GB0011278D0 (en) * 2000-05-10 2000-06-28 Univ London Repair of nerve damage
US7326417B2 (en) 2001-09-11 2008-02-05 Merial Ltd. IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
FR2829498B1 (fr) * 2001-09-11 2003-11-28 Merial Sas Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
GB0202906D0 (en) 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
US20050125914A1 (en) * 2003-11-18 2005-06-16 Gerard Malle Hair shaping composition comprising at least one- non-hydroxide base
JP2008533114A (ja) * 2005-03-18 2008-08-21 ユーシーエル ビジネス パブリック リミテッド カンパニー メカノ成長因子ペプチドおよびその使用
US20090221072A1 (en) * 2006-02-15 2009-09-03 Chen Thomas T Compositions and methods for modulating cell differentiation
CN101466399B (zh) * 2006-06-09 2015-05-13 诺华股份有限公司 稳定的胰岛素样生长因子多肽
AU2007255419A1 (en) * 2006-06-09 2007-12-13 Novartis Ag Stabilized insulin-like growth factor polypeptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963665A (en) 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
SE9100099D0 (sv) 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
US5298422A (en) 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
WO1995013290A1 (en) * 1993-11-12 1995-05-18 North Shore University Hospital Research Corporation Method of treating muscular dystrophy

Also Published As

Publication number Publication date
ATE326534T1 (de) 2006-06-15
US6221842B1 (en) 2001-04-24
DK0894136T3 (da) 2006-09-18
DE69739737D1 (de) 2010-02-25
ES2265649T3 (es) 2007-02-16
EP0894136A1 (de) 1999-02-03
WO1997033997A1 (en) 1997-09-18
DE69735883T2 (de) 2007-04-19
PT1726651E (pt) 2010-04-08
EP1726651B1 (de) 2010-01-06
DK1726651T3 (da) 2010-04-12
GB9605124D0 (en) 1996-05-08
ATE454451T1 (de) 2010-01-15
PT894136E (pt) 2006-10-31
EP0894136B1 (de) 2006-05-17
EP1726651A1 (de) 2006-11-29
JP2000506729A (ja) 2000-06-06
ES2337917T3 (es) 2010-04-30

Similar Documents

Publication Publication Date Title
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
DE69739737D1 (de) Methode zur Behandlung von Muskelkrankheiten
DE3888273D1 (de) Medizinischer Apparat zur Behandlung mit Ultraschall.
DE59607691D1 (de) Anordnung zur elektro-thermischen behandlung des menschlichen oder tierischen körpers
ATE241351T1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
DE69830087D1 (de) Gerät zur therapeutischen Kauterisation von vorbestimmten Volumen biologischen Gewebes
DE69836139D1 (de) Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
ATE247504T1 (de) Vorrichtung zur behandlung des menschlichen körpers durch endermatische elektrotherapie
NO975360D0 (no) Peptid som inhiberer forhöyede triglyceridnivåer i blod og midler som inneholder nevnte peptid som aktiv komponent
DE69129267D1 (de) Methode zur behandlung intestinaler krankheiten
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DE69530570D1 (de) Verfahren zur behandlung von stoehrungen des menschlichen oder tierischen koerpers durch verabreichung von aminosaeuren
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
DE69918145D1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69737029D1 (de) Biomembran zur substitution, rekonstruktion, induktion der angiogenese, neubildung oder regeneration von menschlichen oder tierischen organen oder gewebe
EP0967276A3 (de) Antitumor-Mittel dass Salmosin enthält
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
DE3865283D1 (de) Butylhydroxyanisole zur behandlung von retrovirus-krankheiten.
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
DE69430807D1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ATE336282T1 (de) Katheter zur behandlung von prostaterkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition